Patents by Inventor Kenneth S. Kilgore

Kenneth S. Kilgore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220409627
    Abstract: A method for treating an inflammatory disorder of the lower airways in a human subject in need thereof is described, including administering an effective amount of anakinra directly to the lower airways in the human subject; where the effective amount of anakinra is from about 0.1 mg to about 200 mg per day; and where the inflammatory disorder is selected from the group consisting of a toxic-inhalation lung injury, pulmonary langerhans cell histiocytosis, non-cystic fibrosis bronchiectasis, diffuse panbronchiolitis, acute respiratory distress syndrome (ARDS), reactive airways dysfunction syndrome (RADS), bronchiolitis obliterans organizing pneumonia and pneumonitis.
    Type: Application
    Filed: December 2, 2020
    Publication date: December 29, 2022
    Inventors: Lyn A. BARANOWSKI, Brian A. LORTIE, James P. BISHOP, Kenneth S. KILGORE, William T. SYMONDS, Stephen A. WRING, Jayne E. HASTEDT, Katelyn R. CRIZER, Michelle PALACIOS
  • Publication number: 20100215654
    Abstract: The present invention provides for methods of treating osteoarthritis with IL-6 antagonists such as IL-6 antibodies.
    Type: Application
    Filed: March 16, 2010
    Publication date: August 26, 2010
    Applicants: Pfizer, Inc.
    Inventors: Susan Elizabeth Bove, Kenneth S. Kilgore
  • Publication number: 20080145367
    Abstract: The present invention provides for methods of treating osteoarthritis with IL-6 antagonists such as IL-6 antibodies.
    Type: Application
    Filed: January 31, 2005
    Publication date: June 19, 2008
    Inventors: Susan Elizabeth Bove, Kenneth S. Kilgore
  • Publication number: 20030166706
    Abstract: This invention relates to a method of preventing and treating osteoarthritis and inhibiting cartilage damage by administering a compound which is a 2,3,3a,4,5,6,7,7a-octahydroindol-2-carboxylic acid, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the compound or salt thereof.
    Type: Application
    Filed: February 20, 2003
    Publication date: September 4, 2003
    Inventors: Kenneth S. Kilgore, Denis J. Schrier